Tag : biotechnology

JPMorgan Asset Management Launches Two Active ETFs: JTEK and JDOC
Fintech News

JPMorgan Asset Management Launches Two Active ETFs: JTEK and JDOC

PR Newswire
by PR Newswire0
Funds seek to deliver JPM active management expertise and risk controls through ETF technology JP Morgan Asset Management announced the launch of two actively-managed ETFs, JPMorgan U.S. Tech Leaders ETF (JTEK) and JPMorgan Healthcare Leaders ETF (JDOC) on the Nasdaq Stock Market. JPMorgan U.S. Tech Leaders ETF (JTEK) invests primarily in equity securities......
ViAqua Therapeutics Announces $8.25 Million Investment Led by S2G Ventures to Scale RNA-Based Solutions in Aquaculture
Investment Services News

ViAqua Therapeutics Announces $8.25 Million Investment Led by S2G Ventures to Scale RNA-Based Solutions in Aquaculture

PR Newswire
by PR Newswire0
Funding will enable ViAqua to bring its first product to market, invest in R&D for future products, and prove the platform’s ability to deliver RNA-based solutions at scale. ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health in aquaculture, announced......
COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital
Fintech News

COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital

Business Wire
by Business Wire0
COMPASS Pathways plc, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that the Company has entered into a term loan agreement with Hercules Capital, for up to $50 million. Latest Fintech Interview: Global Fintech Interview with Paul Monk, Chief Executive Officer at Alpha Development......
Prasad Parmeshwaran Joins Lazard as a Managing Director in Healthcare Group, Financial Advisory
Finance News

Prasad Parmeshwaran Joins Lazard as a Managing Director in Healthcare Group, Financial Advisory

Fintech News Desk
by Fintech News Desk0
Lazard Ltd announced that Prasad Parmeshwaran has joined the firm as a Managing Director in the Healthcare Group within Financial Advisory, effective immediately. Based in San Francisco, Mr. Parmeshwaran primarily advises clients on financial matters in the biotechnology and diagnostics sectors. Latest Fintech News: Workday Global Survey Finance and IT Leaders......
Athersys to Present at the Bank of America Virtual Healthcare Conference on May 12
Banking Finance News

Athersys to Present at the Bank of America Virtual Healthcare Conference on May 12

Fintech News Desk
by Fintech News Desk0
Ivor Macleod, Chief Financial Officer of Athersys Inc., is scheduled to speak at the Bank of America Securities 2021 Virtual Health Care Conference on Wednesday, May 12, 2021 at 12:30 pm EDT. Following a brief corporate update, Mr. Macleod will engage in a Q & A fireside chat with a......
AC Milan to Join Sports Crypto Movement with Launch of $ACM Fan Token
News

Blackstone Announces Appointment of Jeffrey B. Kindler, Former Chairman and CEO of Pfizer, as Senior Advisor

Fintech News Desk
by Fintech News Desk0
Blackstone (NYSE:BX) today announced the appointment of Jeffrey B. Kindler, former Chairman and CEO of Pfizer and current CEO of Centrexion Therapeutics, as a Senior Advisor. Mr. Kindler will bring his deep management experience and wide-ranging expertise in the healthcare sector to advise across the firm’s businesses and portfolio companies,......
AEGIS Selects expert.ai to Enhance Their Data Strategy with AI-based Natural Language Understanding
Fintech News

Revance Completes Previously Announced Acquisition of HintMD and its Proprietary Fintech Platform for Aesthetic Practices

Fintech News Desk
by Fintech News Desk0
Revance Therapeutics, a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational neuromodulator product, DaxibotulinumtoxinA for Injection, announced the completion of its previously announced acquisition of Hint, Inc., a privately held company doing business under the name HintMD. Revance issued a total of 8,572,213 shares of common......
Revance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices
Fintech News

Revance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices

Fintech News Desk
by Fintech News Desk0
Revance Therapeutics, a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection, announced the signing of a definitive agreement to acquire Hint, Inc., a privately held company doing business under the name HintMD, which has created an integrated financial technology (fintech) platform......
1